Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
7.13
-1.08 (-13.15%)
At close: Jun 26, 2026, 4:00 PM EDT
7.36
+0.23 (3.29%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Unicycive Therapeutics Employees
As of December 31, 2025, Unicycive Therapeutics had 22 total employees, including 21 full-time and 1 part-time employees. The number of employees decreased by 1 or -4.35% compared to the previous year.
Employees
22
Change (1Y)
-1
Growth (1Y)
-4.35%
Revenue / Employee
n/a
Profits / Employee
-$1,813,091
Market Cap
190.37M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Karyopharm Therapeutics | 228 |
| Fate Therapeutics | 161 |
| Coherus Oncology | 145 |
| Voyager Therapeutics | 141 |
| Alector | 103 |
| Keros Therapeutics | 87 |
| Orchestra BioMed Holdings | 86 |
| Protara Therapeutics | 46 |
UNCY News
- 6 days ago - Unicycive Therapeutics Proxy statement: Proxy filing - Filings
- 23 days ago - Unicycive Therapeutics files $150M mixed securities shelf - TheFly
- 23 days ago - Unicycive Therapeutics Registration statement: Registration filing - Filings
- 24 days ago - Unicycive Therapeutics Slides: Corporate presentation - Filings
- 26 days ago - Unicycive Therapeutics price target raised to $18 from $15 at Benchmark - TheFly
- 27 days ago - Unicycive Therapeutics Earnings release - Filings
- 27 days ago - Unicycive Therapeutics Earnings release - Filings
- 27 days ago - Unicycive Therapeutics Earnings release - Filings